← back to search

Orkhan Isayev

Azerbaijan Medical University · AZ
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, MicroRNA in disease regulation, and Cancer Immunotherapy and Biomarkers.
h-index
8
citations
317
works
25
NIH funding
primary concept
email

Recent publications

CD96 as a Potential Immune Regulator in Cancers
International Journal of Molecular Sciences 2023cited by 31position: middledoi
Experimental postoperative ileus: is Th2 immune response involved?
International Journal of Medical Sciences 2021cited by 8position: middledoi
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Oncotarget 2014cited by 66position: firstdoi
Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication
Oncotarget 2014cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alexandr V. Bazhin · Deutschen Konsortium für Translationale Krebsforschung3 papers (2014–2023)Clifford C. Nwaeburu · Heidelberg University2 papers (2014–2014)Vanessa Rausch · Heidelberg University2 papers (2014–2014)Wolfgang Groß · University of Bayreuth2 papers (2014–2014)Jens Werner · University Hospital Heidelberg2 papers (2014–2021)Jury Gladkich · Heidelberg University2 papers (2014–2014)Ingrid Herr · Heidelberg University2 papers (2014–2014)Yiyao Zhang · Jinan University2 papers (2014–2014)Nathalie Bauer · University of Münster1 papers (2014–2014)Clarissa Gerhäuser · The University of Melbourne1 papers (2014–2014)Jens Werner · LMU Klinikum1 papers (2023–2023)Pei Fan · Northwestern Polytechnical University1 papers (2014–2014)Uwe Haberkorn · German Cancer Research Center1 papers (2014–2014)Peter Schemmer · Medical University of Graz1 papers (2014–2014)Shikai Feng · Ludwig-Maximilians-Universität München1 papers (2023–2023)Andrey A. Zamyatnin · Harbin Medical University1 papers (2021–2021)Tobias S. Schiergens · LMU Klinikum1 papers (2021–2021)Michelle Neßling · Heidelberg University1 papers (2014–2014)Katharina Heilmann · Epigenomics (Germany)1 papers (2014–2014)Martin Mollenhauer · Technical University of Munich1 papers (2014–2014)